Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASLR.L Regulatory News (ASLR)

  • There is currently no data for ASLR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re Suspension

14 Feb 2020 16:52

RNS Number : 1166D
Asimilar Group PLC
14 February 2020
 

 

Asimilar Group plc

("Asimilar" or the "Company")

Statement re Suspension

Asimilar Group Plc, the AIM quoted investment company focused on technology opportunities in the fields of big data, machine learning, telematics and the Internet of Things (IoT) notes a press article that states that the Company is to acquire a stake in a Belgium AI company named Sentiance NV ("Sentiance").

The Board confirms that the Company has signed a non-binding term sheet concerning an investment in Sentiance, which, subject to contract, may or may not be considered to be a reverse takeover transaction. Whilst work continues on this investment, the Company's shares have been suspended pursuant to AIM Rule 40.

The Company's shares will remain suspended until such time as the Company publishes an admission document or discussions in relation to a possible reverse takeover transaction cease.

The Company is continuing to work with Sentiance to finalise binding legal documentation, although there is no guarantee that a formal agreement will be reached.

Further announcements will be made in due course.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

**ENDS**

Enquiries

Asimilar Group plc

John Taylor, Non-Executive Chairman

via Buchanan

Cairn Financial Advisers LLP

Sandy Jamieson, Liam Murray

Tel: +44 20 7213 0880

Peterhouse Capital Limited

Duncan Vasey / Lucy Williams

Tel: + 44 20 7220 9797

Buchanan Communications Limited

Richard Oldworth / Chris Lane

Tel: +44 (0) 20 7466 5000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRKKQBQABKDDBD
Date   Source Headline
18th Nov 20057:01 amRNSPositive Product Test Results
20th Oct 20057:00 amRNSTrading Statement
1st Aug 20059:27 amRNSBoard Appointment
29th Jul 20057:01 amRNSEgypt contract gain
8th Jul 200512:14 pmRNSResult of EGM
29th Jun 20055:30 pmRNSInterim Results
21st Jun 20057:00 amRNSOverseas Contract Gains
15th Jun 20054:03 pmRNSNotice of EGM
15th Jun 20052:21 pmRNSBoard Appointment
10th Jun 20057:00 amRNSOverseas Contract Gains
2nd Jun 20057:01 amRNSUS Collaboration deal
25th May 200512:30 pmRNSIssue of Equity
29th Mar 20051:13 pmRNSAGM Statement
2nd Feb 20054:51 pmRNSFinal Results Replacement
14th Jan 20051:39 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.